What this instrument does
The National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (July Update) Instrument 2026 is a technical update to the National Health (Highly Specialised Drugs Program) Special Arrangement 2021. It was made under the National Health Act 1953.
The instrument amends the rules around how certain highly specialised drugs are supplied and subsidised through the Pharmaceutical Benefits Scheme.
Operative period
The instrument was in force from 30 June 2026 to 12 October 2026 and has since been repealed or superseded by a later version.
What is not specified
The source does not specify which drugs, dosages, or supply arrangements were changed. Pharmacy and health businesses needing detail are required to check the full legislative text and explanatory statement directly.
Key actions
- Visit the full legislative text and explanatory statement for the specific drug list and arrangement changes
- Pharmacies or businesses that supply highly specialised drugs under this program can check whether current practices align with the amended 2021 arrangement
- This instrument's operative period has already ended (12 October 2026) - the Federal Register can be checked for any later version that may now apply
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.